Rhinathiol Cold

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Rhinathiol Cold

Property Description
Active Ingredients Ibuprofen, Pseudoephedrine
Form Oral Solid (Tablets/Capsules)
Pharmacological Class NSAID & Systemic Decongestant
Common Use Symptomatic relief of cold/flu discomfort
Origin Synthetic/Chemically derived

What Type of Medicine is Rhinathiol Cold?

Rhinathiol Cold is classified as a fixed-dose combination (FDC) medicine, meaning it is a single oral preparation containing two distinct, chemically derived active substances. The product combines an agent from the Nonsteroidal Anti-inflammatory Drug (NSAID) class and a Systemic Decongestant. These combinations are recognized for the symptomatic relief of cold and flu symptoms associated with nasal congestion and related pain or fever. This FDC format offers a standardized, multi-action alternative to taking separate single-ingredient medicines.


Composition and Form: The Dual-Action Ingredients

The two active ingredients in this formulation are Ibuprofen and Pseudoephedrine. The medicine is supplied as an oral solid form, typically tablets or capsules, intended for oral administration. Ibuprofen is incorporated to address pain and fever, while Pseudoephedrine acts as a decongestant. Ibuprofen is an established drug for reducing fever and pain. The combination is specifically positioned for patients experiencing both body aches and a stuffy nose, providing a focused, dual-action solution that distinguishes it from medications containing only one of the components.


What is the General Purpose of This Combination Drug?

The primary general purpose of Rhinathiol Cold is to provide symptomatic relief for the overall discomfort caused by a cold or flu. For instance, it is typically used when a patient is suffering from a headache and body aches coupled with significant nasal congestion. This combination is utilized because its composition provides a comprehensive, systematic approach to simultaneously alleviating these two different classes of symptoms. The formulation relies on the properties of both NSAIDs and decongestants in treating general cold manifestations.

Regulatory References

  1. Pseudoephedrine-containing medicinal products - referral
  2. Ibuprofen: MedlinePlus Drug Information
  3. Ibuprofen - StatPearls - NCBI Bookshelf

What side effects are possible with Rhinathiol Cold?

Possible Side Effects and Safety Information

The official safety profile for the Ibuprofen and Pseudoephedrine combination is documented by regulatory bodies, classifying adverse reactions primarily by frequency and the body system affected. These classifications establish the expected side effect profile and highlight potential serious risks.


Official Adverse Reactions and Classification

Adverse effects are categorized into System-Organ Classes (SOCs) such as Gastrointestinal Disorders and Nervous System Disorders. Common effects officially listed include headache, dizziness, insomnia, and general gastrointestinal discomfort (e.g., nausea, abdominal pain).

Frequency Classification Examples of Affected Systems
Common Nervous System, Gastrointestinal
Uncommon / Rare Cardiac/Vascular, Immunological, Skin

Serious Adverse Reactions

Regulatory warnings explicitly document the potential for serious cardiovascular thrombotic events, including heart attack and stroke, which can be fatal. The combination is also associated with a risk of gastrointestinal bleeding, ulceration, and perforation. Furthermore, rare but severe reactions like anaphylaxis and certain severe cutaneous adverse reactions are officially documented.


Population-Specific Safety Considerations

The safety profile includes restrictions for certain patient groups. Individuals aged 60 or older have an increased risk of fatal gastrointestinal bleeding. The medicine is contraindicated during the third trimester of pregnancy due to specific fetal risks. Additionally, restrictions apply to patients with severe renal insufficiency or uncontrolled severe hypertension.

Overdose and Emergency Response

Overdose and when to seek help

Overdose of this combination medicine, which contains Ibuprofen and Pseudoephedrine, can result in serious, life-threatening manifestations documented in regulatory labeling. The symptom profile reflects toxicity from both active components.

Documented overdose presentations include signs of Central Nervous System (CNS) overstimulation, such as agitation, confusion, tremor, and convulsions (seizures), alongside high or low blood pressure and arrhythmias. Physiological systems affected also include the Gastrointestinal tract, presenting with nausea, vomiting, abdominal pain, and the risk of GI bleeding. Severe outcomes officially noted are acute renal failure, metabolic acidosis, stroke, and cardiovascular collapse.

When to Seek Immediate Medical Help

Due to the severity of these documented effects, official regulatory guidance mandates that any suspected overdose requires immediate medical attention or contact with emergency services.

Management is strictly symptomatic and supportive. Regulatory documents confirm that no specific antidote is known. Procedures described in the overdose section include the administration of activated charcoal and hospital monitoring of vital signs and organ function. Special considerations apply to the elderly (increased GI risk) and children (increased CNS and CV risk).

Therapeutic Uses of Rhinathiol Cold

What Rhinathiol Cold Treats: Main Uses and Benefits

Rhinathiol Cold is relevant in settings that involve acute cold and flu symptoms, focusing on conditions characterized by temporary physiological imbalance. The combination product is used for managing symptoms that cluster into patterns requiring supportive management. This includes symptoms related to systemic imbalance such as headaches, minor body aches and pains, and fever, along with the localized discomfort of nasal congestion and sinus pressure. The medication plays a role in managing symptom clusters that may become intense or disruptive, contributing to improved day-to-day comfort during symptomatic periods. This formulation is applied where additional symptomatic support is needed when the overlap of pain and congestion is disruptive.

“It is commonly used when short-term symptomatic assistance is needed for acute episodes marked by heightened patient distress.”

Therapeutic Focus: Dual Symptom Support

The therapeutic approach is relevant for easing symptoms that interfere with daily comfort, and may assist with maintaining functional stability while contributing to easing the overall symptom load.

Regulatory References

  1. National Library of Medicine (DailyMed)

Eligibility and Restrictions for Use

Rhinathiol Cold is subject to strict eligibility rules documented in official regulatory labeling and is not suitable for all patients.

Eligibility and Exclusion Rules

The medicine is formally indicated for use by adults and children 12 years of age and over. Use is contraindicated in children under 12 years of age as safety and efficacy have not been established in this younger population.

Category Regulatory Status Constraint Details
Cardiovascular Status Contraindicated Severe heart failure, uncontrolled/severe hypertension, or immediately before or after heart surgery.
Gastrointestinal Health Contraindicated Active peptic ulcer or a history of recurrent ulceration/bleeding related to NSAID use.
Hypersensitivity Contraindicated Known allergy to Ibuprofen, Pseudoephedrine, aspirin, or any other Nonsteroidal Anti-inflammatory Drug (NSAID).
Concomitant Use Contraindicated Current use of, or use within 14 days of stopping, a Monoamine Oxidase Inhibitor (MAOI).
Pregnancy Contraindicated Use during the third trimester of pregnancy (20 weeks gestation and later).
Lactation Not Recommended Use while breastfeeding is generally advised against.

Eligibility is also restricted for patients with severe hepatic or renal failure. Individuals with underlying conditions such as diabetes, high blood pressure, or thyroid disease must exercise caution, as explicitly stated in the prescribing information.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents detail specific drug interactions related to the active components of Rhinathiol Cold (which commonly include a sympathomimetic like phenylephrine and an antihistamine like chlorphenamine).

Contraindicated Combinations

The most significant restriction is the absolute contraindication for co-administration with Monoamine Oxidase Inhibitors (MAOIs) or within two weeks following the cessation of MAOI therapy. This is due to the potential for MAOIs to inhibit the metabolism of phenylephrine, leading to a dangerous increase in blood pressure and adrenergic activity.

Combinations Requiring Caution

Special caution is required with concurrent use of other sympathomimetics or certain anesthetics (e.g., trichloroethylene, halothane) that sensitize the myocardium, as these combinations increase the risk of cardiovascular effects. The product also requires caution when used alongside CNS depressants, including alcohol, sedatives, tranquilizers, and certain hypnotics or neuroleptics. This is because chlorphenamine can potentiate central nervous system depression.

Other Documented Interactions

Regulatory information for formulations containing Carbocisteine also notes interactions. Specifically, co-administration with Amoxicillin may increase the toxicity of Amoxicillin, while Cimetidine may reduce the renal excretion of Carbocisteine, affecting its exposure profile.

Mechanism of Action

The mechanism of action for Rhinathiol Cold is achieved through targeted activity across three distinct pharmacodynamic domains.

One component operates by inhibiting cyclooxygenase (COX) enzymes, which are instrumental in the molecular cascade that synthesizes prostaglandins. This enzymatic inhibition limits the production of key signaling mediators, thus modulating the activation of pathways associated with thermal and nociceptive signaling.

Another active substance functions as an antagonist at the Histamine H1 receptor. This interaction competitively blocks the binding of the inflammatory transmitter histamine, thereby suppressing the molecular signaling sequences typically initiated by its release.

Finally, the third component influences peripheral vascular dynamics by stimulating alpha-adrenergic receptors on mucosal blood vessels. Activation of these receptors initiates an intracellular cascade leading to vasoconstriction, which reduces the volume of the local vasculature and modifies activity within the targeted peripheral pathways.

Dosage and Administration Information

Official Administration Guidelines

Rhinathiol Cold, a fixed-dose combination product containing Ibuprofen and Pseudoephedrine HCl, is utilized via the oral route as tablets, caplets, or liquid-filled capsules. The administration protocol is established to standardize use and total exposure.


Dosing and Frequency

Feature Standard Labeled Instruction
Route of Administration Oral only.
Standard Unit Dose One or two units (200 mg Ibuprofen / 30 mg Pseudoephedrine HCl per unit) per dose for adults and children 12 years of age and over.
Frequency Doses are to be taken every four to six hours while symptoms persist.
Maximum Daily Limit Administration must not exceed six units in any 24-hour period.

Use Conditions and Constraints

The label specifies the smallest effective dose should be employed as a core administration principle. In the event of gastric discomfort, the medication may be taken with food or milk.

Administration is restricted to adults and children 12 years of age and over; the product is not for use in children under this age. Furthermore, the use pattern is defined as short-term for symptomatic relief. Nasal congestion treatment should not exceed seven days, establishing a constraint on the duration of the treatment course.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Rhinathiol Cold


Evidence for Symptomatic Relief of Acute Cold Symptoms

The research exploring this medicine, which combines Ibuprofen and Pseudoephedrine, primarily uses short-term Randomized Controlled Trials (RCTs) and subsequent meta-analyses. These trials are relevant in studies assessing short-term or episodic symptom patterns and are used in research exploring how symptoms change over time. The studies focused on patient-reported outcomes describing perceived discomfort linked to the common cold or flu.

Researchers in these trials have focused on outcomes related to physical discomfort and systemic imbalance. They assessed patient-reported outcomes related to the severity and duration of key symptoms, particularly headache, minor body aches, fever, and nasal blockage/stuffiness. These studies were conducted during periods of increased symptom activity, and evidence contributes to understanding these symptom patterns. Some trials described patterns observed in the studies when comparing measurements during the study period to the group receiving placebo.


Comparison of Research Findings Against Placebo

Research has explored the differences in measured outcomes for the combination medicine when compared to a placebo across outcomes capturing phases of heightened symptom activity. The comparison explored whether the outcomes measured after administering the combined ingredients differed from those reported by patients taking no active medicine.

Studies explored the observed differences in functional measures and outcomes related to systemic or functional imbalance. For instance, researchers examined outcomes related to the observed time intervals until symptom scores changed, and the overall duration over which these changes were reported by the populations. The combined research evidence, including systematic reviews, describes short-term symptom patterns observed in patients who experienced difficulty with daily activities due to a cold.


Research on Study Duration and Long-Term Outcomes

Data on long-term outcomes for the combination in this context are not fully established by the existing research. Follow-up durations in the main clinical trials were designed to be short-term, typically observing patients for the period of acute cold symptoms (one to seven days). Studies exploring repeated or extended use over several cold seasons are insufficient.


Evidence Landscape in Specific Study Groups

The research has primarily examined outcomes in generally healthy Adults and Adolescents (typically 12 years and older) who are experiencing acute cold symptoms. Data for certain groups remain insufficient, and results apply mainly to the populations studied. Evidence is limited for specific groups such as older adults or individuals with pre-existing chronic health conditions.

Frequently Asked Questions (FAQ)

Common questions about Rhinathiol Cold (FAQ)


Q: Is Rhinathiol Cold available without a prescription?

A: This type of combination medicine, which includes Ibuprofen and Pseudoephedrine, is commonly sold without a prescription (Over-The-Counter or OTC) in many countries. Official instructions advise following the directions printed on the packaging for non-prescription use.


Q: Why do some packages list two or three different medicines in Rhinathiol Cold?

A: Official products, such as those reviewed in the US and Canada, are generally a fixed-dose combination of two active ingredients: Ibuprofen and Pseudoephedrine. Confusion may arise because cold medicines with similar brand names in different global regions might contain different ingredients, leading to variations in formula.


Q: What is the difference between Rhinathiol Cold and a plain decongestant?

A: Rhinathiol Cold is a combination medicine that contains two active agents. It includes both a pain reliever and fever reducer (Ibuprofen) and a nasal decongestant (Pseudoephedrine). In contrast, a plain decongestant contains only the decongestant component to relieve nasal blockage.


Q: Can I take Rhinathiol Cold if I am taking painkillers for a headache?

A: Regulatory documents indicate that concurrent use of this medicine with other Nonsteroidal Anti-inflammatory Drugs (NSAIDs) like Ibuprofen or Aspirin is generally not recommended or should be avoided. This is due to a potential increase in the risk of side effects, particularly affecting the stomach.


Q: Is there a known interaction between Rhinathiol Cold and alcohol?

A: Official product information notes that use of this product with alcohol may increase certain risks. Combining Ibuprofen with alcohol may increase the risk of serious stomach bleeding. Regulatory warnings also indicate that alcohol may enhance effects, such as drowsiness, associated with components that affect the central nervous system.


Q: Can people with high blood pressure use Rhinathiol Cold?

A: Official product information states that the medicine should not be used by patients with severe or uncontrolled high blood pressure (hypertension). This restriction is related to the decongestant component, which acts to narrow blood vessels and may be associated with increasing blood pressure.


Q: Can older adults use Rhinathiol Cold, and are there special warnings?

A: Regulatory documents state that patients aged 60 or older should use this medicine with caution. Older adults may have an increased risk of specific side effects, including the potential for fatal gastrointestinal bleeding associated with the Ibuprofen component.


Q: Does Rhinathiol Cold cure the cold, or does it only manage symptoms?

A: According to official uses, the product is intended only to provide temporary relief for the symptoms associated with the common cold or flu. It is not described as a treatment or cure for the underlying viral infection.


Q: How is the safety of Rhinathiol Cold monitored by regulatory bodies?

A: Major regulatory agencies continuously monitor the safety of this medicine. They do this by gathering and reviewing safety data reported globally through mechanisms like the Periodic Safety Update Report Single Assessment (PSUSA) to assess the overall risk profile.


Q: Is this medicine suitable for general flu symptoms or only the common cold?

A: Official product labels state that the medicine is indicated for the temporary relief of symptoms associated with both the common cold and the flu.


Q: Why are people often told to check the ingredients of other medicines when taking Rhinathiol Cold?

A: Official warnings emphasize checking other products for the presence of the same active ingredients, particularly Pseudoephedrine or Ibuprofen. This helps a person avoid taking too much of any single ingredient, which is a major safety concern that could increase the risk of side effects.


Q: Does the medicine come in different formulations (e.g., tablet, liquid, capsule)?

A: The combination of Ibuprofen and Pseudoephedrine is commonly available in several oral dosage forms. These typically include tablets, caplets, and liquid-filled capsules.


Q: Is it important to take Rhinathiol Cold at a specific time of day?

A: Official instructions specify that the doses are to be taken every four to six hours while symptoms persist. The label also advises that the medicine may be taken with food or milk if stomach upset occurs, but there is no specific required time of day.


Q: What should be done if someone accidentally takes too much Rhinathiol Cold?

A: Official guidance related to potential overdose situations describes contacting a national poison control center or seeking emergency medical help as the recommended action. Symptoms of overdose can include stomach pain, vomiting, or changes in the nervous system.


Q: Is Rhinathiol Cold intended for symptoms like runny nose, blocked nose, or both?

A: The product is officially used for symptoms including nasal congestion (a blocked nose) and sinus pressure. The active decongestant component works to relieve this stuffiness.


Q: Does Rhinathiol Cold interact with antidepressant medications?

A: Official documents list a major contraindication for co-administration with Monoamine Oxidase Inhibitors (MAOIs), which are a class of antidepressant. Caution is also generally recommended with other antidepressants, such as Tricyclic Antidepressants (TCAs), due to potential risks from the Pseudoephedrine component.


Q: Can I use Rhinathiol Cold if I have diabetes?

A: Official product information states that individuals living with diabetes must be cautious when considering the use of this medicine. The decongestant component (Pseudoephedrine) may affect blood sugar levels, and regulatory guidance recommends caution with its use.


Q: What is the general safety profile of the combined ingredients in Rhinathiol Cold?

A: The official safety profile describes common side effects which can include headache, dizziness, and stomach upset. It also carries warnings about the potential for rare but serious events, including cardiovascular issues (like heart attack and stroke) and severe gastrointestinal risks (bleeding and ulceration).


Q: Does taking Rhinathiol Cold affect the ability to operate machinery?

A: The official list of potential side effects includes nervous system symptoms such as dizziness and sleeplessness. It is noted that these effects may be associated with an impact on the ability to operate machinery or drive.


Q: Is it necessary to stop taking other regular medicines before starting Rhinathiol Cold?

A: Official instructions highlight the importance of informing a healthcare provider about all other prescription and nonprescription medications being taken. The label notes that concurrent use with MAOIs is strictly contraindicated, often requiring cessation at least two weeks prior to use. Otherwise, changes to regular medications should only occur under the direction of a healthcare professional.


Q: Can people with asthma or breathing problems use Rhinathiol Cold?

A: Regulatory documents indicate that the Ibuprofen component includes an Allergy Alert. This means it may cause a severe allergic reaction, especially in people allergic to aspirin, with symptoms that can include asthma or wheezing.


Q: Are there specific food or drink interactions mentioned for Rhinathiol Cold?

A: The primary interaction mentioned on the official label is with alcohol, which can increase the risk of stomach bleeding. The medicine may be taken with food or milk to reduce the chance of general stomach upset.


Q: Can Rhinathiol Cold be used for children under 12?

A: Official regulatory guidance states that the medicine should not be used for children younger than 12 years of age. This is because the safety and effectiveness of this specific combination product have not been established in this younger age group.


Q: Are there any known issues with taking Rhinathiol Cold for more than a few days?

A: Official label instructions advise against using the medicine for longer than directed. Taking the medicine for an extended period, typically more than 7 days for nasal congestion, increases the risk of side effects, including the potential for high blood pressure and other serious cardiovascular issues.


Q: What is the purpose of the decongestant in the Rhinathiol Cold formula?

A: The purpose of the decongestant component (Pseudoephedrine) is to act as a systemic decongestant. It works to provide temporary relief for symptoms like nasal congestion and sinus pressure that are common with colds.


Q: What is the evidence base for using the ingredients in Rhinathiol Cold together?

A: The rationale for this fixed-dose combination is to provide dual action. The Ibuprofen component is included to relieve pain and fever, while the Pseudoephedrine component is included to relieve nasal congestion, allowing the product to simultaneously address the main symptoms of a cold.


Q: Has Rhinathiol Cold been reviewed by major medical agencies like the EMA or FDA?

A: Yes. Products containing the combination of Ibuprofen and Pseudoephedrine have been subject to regulatory review and assessment by major agencies like the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) for use in treating cold and flu symptoms.


Q: Why is Rhinathiol Cold sometimes classified as a combination drug?

A: It is officially classified as a fixed-dose combination (FDC) drug because it contains two distinct active ingredients in a single dosage unit. The single product combines a pain reliever/fever reducer (Ibuprofen) with a nasal decongestant (Pseudoephedrine).

How should Rhinathiol Cold be stored and disposed of?

How to Store and Dispose of Rhinathiol Cold?

The official regulatory labeling for Rhinathiol Cold (Ibuprofen/Pseudoephedrine oral solid) specifies strict conditions for storage and disposal to ensure stability and environmental protection.


Storage Requirements

Condition Regulatory Statement
Temperature Store at controlled room temperature, typically between 20 C to 25 C (68 F to 77 F). Do not refrigerate and avoid excessive heat.
Protection Store in the original container, keep the container tightly closed, and protect from high humidity.
Safety Keep the medicine out of the sight and reach of children.
Stability Do not use the medicine after the expiration date printed on the packaging.

Disposal Instructions

Expired or unused Rhinathiol Cold must not be thrown away with household waste or disposed of via wastewater. The product must be returned to a pharmacy or disposed of according to local regulations for pharmaceutical waste, as instructed by governmental guidelines.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Rhinathiol Cold found in:

A-Z Index: